Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China · Delayed Price · Currency is CNY

32.37

+0.31 (0.97%)

Feb 27, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Preparations	546.98M	649.61M	933.28M	973.90M	1.05B
Preparations Growth	-15.80%	-30.39%	-4.17%	-6.83%	-4.61%
API(Active Pharmaceutical Ingredients) and Intermediates	747.44M	806.92M	607.17M	389.69M	230.16M
API(Active Pharmaceutical Ingredients) and Intermediates Growth	-7.37%	32.90%	55.81%	69.31%	-15.15%
Featured Intermediates	200.10M	149.68M	-	-	-
Featured Intermediates Growth	33.69%	-	-	-	-
Pharmaceutical Excipients	18.58M	14.30M	19.90M	11.31M	9.98M
Pharmaceutical Excipients Growth	29.87%	-28.13%	75.98%	13.34%	-28.13%
Others	24.78M	5.35M	8.09M	5.48M	4.17M
Others Growth	363.29%	-33.85%	47.68%	31.19%	-72.47%
Total	1.54B	1.63B	1.57B	1.38B	1.29B
Total Growth	-5.41%	3.66%	13.62%	7.04%	-7.63%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	1.14B	1.26B	1.45B	1.31B	1.26B
China Growth	-9.17%	-13.48%	10.47%	4.00%	-7.84%
Export	397.57M	370.42M	117.33M	66.76M	26.59M
Export Growth	7.33%	215.71%	75.76%	151.10%	3.53%
Total	1.54B	1.63B	1.57B	1.38B	1.29B
Total Growth	-5.41%	3.66%	13.62%	7.04%	-7.63%

Source: S&P Global Market Intelligence.